RxDoctor Payments Data

Ashley Snyder

Family · Mesa, AZNPI 1528748043

Payments from drug & device makers

$4,004in general payments, 2019–2025

Across 185 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$823
  • AbbVie$479
  • Pfizer$451
  • Lilly USA, LLC$322
  • Novo Nordisk$318
  • GSK$286
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$4,004100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,004 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.

See all family providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol16$15,327
Levemir FlexpenInsulin Detemir14$6,206
Humalog Kwikpen U-100Insulin Lispro12$5,935
SynthroidLevothyroxine Sodium11$610
Omeprazole21$471
Albuterol Sulfate HfaAlbuterol Sulfate24$372
Methylprednisolone38$305
Levothyroxine Sodium27$281
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav34$231
Ciprofloxacin Hcl13$179
Alendronate Sodium15$164
Rosuvastatin Calcium19$161
Gabapentin14$156
Doxycycline Hyclate13$150
Tamsulosin Hcl11$136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$823$15,32716 claims
AbbVieSynthroid$479$61011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.

Other family in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →